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Abstract
Recognition of peptide Major Histocompatibility Complexes (MHC) by the T cell receptor causes rapid production of
reactive oxygen intermediates (ROI) in naïve CD8+ T cells. Because ROI such as H2O2 are membrane permeable,
mechanisms must exist to prevent overoxidation of surface proteins. In this study we used fluorescently labeled
conjugates of maleimide to measure the level of cell surface free thiols (CSFT) during the development, activation
and differentiation of CD8+ T cells. We found that during development CSFT were higher on CD8 SP compared to
CD4 SP or CD4CD8 DP T cells. After activation CSFT became elevated prior to division but once proliferation started
levels continued to rise. During acute viral infection CSFT levels were elevated on antigen-specific effector cells
compared to memory cells. Additionally, the CSFT level was always higher on antigen-specific CD8+ T cells in
lymphoid compared to nonlymphoid organs. During chronic viral infection, CSFT levels were elevated for extended
periods on antigen-specific effector CD8+ T cells. Finally, CSFT levels on effector CD8+ T cells, regardless of
infection, identified cells undergoing TCR stimulation. Taken together these data suggest that CD8+ T cells
upregulate CSFT following receptor ligation and ROI production during infection to prevent overoxidation of surface
proteins.
Citation: Pellom ST, Michalek RD, Crump KE, Langston PK, Juneau DG, et al. (2013) Increased Cell Surface Free Thiols Identify Effector CD8+ T Cells
Undergoing T Cell Receptor Stimulation. PLoS ONE 8(11): e81134. doi:10.1371/journal.pone.0081134
Editor: Steven M. Varga, University of Iowa, United States of America
Received June 11, 2013; Accepted October 18, 2013; Published November 13, 2013
Copyright: © 2013 Pellom et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institute of Allergy and Infectious Diseases (NIAD) grant RO1-AI068952 to J.M.G. K.E.C. and R.D.M. were
supported by NIAID grant 5T32AI007401-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: Ryan Michalek is employed by Metabolon Corporation. There are no patents, products in development or marketed products to
declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: jgrayson@wakehealth.edu
Introduction
CD8+ T cells are critical for protection from intracellular
pathogens such as viruses and certain bacteria and are critical
to tumor control. Prior to infection naïve CD8+ T cells circulate
through the spleen and secondary lymphoid organs surveying
professional antigen presenting cells for their cognate antigen.
In the absence of cognate stimulation they die within six
months [1]. But if antigen is encountered along with
costimulation and inflammatory cytokines, naïve CD8+ T cells
differentiate into effector cells. As part of this programmed
differentiation CD8+ T cells now express molecules such as
perforin and granzymes that are essential to killing infected
cells and cytokines such as interferon gamma (IFNγ), tumor
necrosis factor alpha (TNFα) and interleukin-2 (IL-2). In
addition to expression of cytolytic molecules, effector cells
undergo 10 to 12 divisions to amplify numbers with expansion
peaking ~ one week later. From days 8 to 35 the number of
antigen-specific cells declines 10 to 20-fold. The surviving
antigen-specific CD8+ T cells differentiate into memory CD8+ T
cells that undergo a slow homeostatic proliferation to maintain
numbers and are able to rapidly respond during secondary
infection to control disease [2]. Understanding the mechanisms
that control CD8+ T cell activation, proliferation and
differentiation is critical not only for vaccine development but
also for graft rejection and cancer therapy.
Prior work from our laboratory has demonstrated that
activation of naïve CD8+ T cells elicits ROI production [3]. This
increase is essential because antioxidants that lower ROI,
decrease activation and proliferation [4]. The mechanisms by
which ROI control T cell activation have been the subject of
intense research. Since ROI can oxidize all macromolecules
determining the relevant oxidation targets is essential.
Reversible modulation of cysteine oxidation is an attractive
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mechanism for ROI to influence cellular function. Indeed
studies by our laboratory and others have demonstrated that
activation increases sulfenic acid (-SOH), the first oxidation
product of cysteine, both in the total proteome, and in protein
tyrosine phosphatases such as SHP-1 and SHP-2 [3,5]. The
reversible formation of this molecule is absolutely necessary for
the proliferation of CD4+ and CD8+ T [3] and B cells [6]. To date
most studies have focused on intracellular redox events, but
evidence suggests cysteine oxidation at the cell surface is
essential for T cell activation and function. In 1980 Redelman
et. al [7] demonstrated that allogeneic cell-mediated lysis
required surface sulfhydryl groups as thioylte monoquat, which
is not cell permeant, decreased killing. Smith and colleagues
demonstrated that free thiol binding reagents including N-
ethylmaleimide (NEM) were able to inhibit T cell proliferation
through the loss of IL-2 responsiveness [8]. These findings
were extended by Lawrence et al. who demonstrated that 5,5’-
dithiobis-(2-nitrobenzoic acid) (DTNB), a cell impermeant
surface thiol binding reagent, was able to inhibit proliferation of
human PBMCs [9]. Taken together they suggest that redox
regulation of CSFT is critical for T cell activation and function.
How CSFT are regulated during the development and
differentiation of antigen-specific CD8+ T cells during a
physiological response such as viral infection is unknown.
In this study we used fluorescently labeled conjugates of
maleimide and MHC Class I tetramers to examine how CSFT
levels were modulated during CD8+ T cell development,
activation, and differentiation following viral infection. We found
that developing CD8 SP T cells had increased CSFT relative to
CD4 SP or CD4CD8 DP T cells in the thymus. Once CD8+ T
cells emigrated to the periphery CSFT levels were higher on
activated/memory compared to naïve phenotype CD8+ T cells.
After activation CSFT levels increased prior to division and
became further elevated as cells proliferated. During acute viral
infection CSFT levels were elevated on antigen-specific
effector cells compared to memory cells. Additionally, the
CSFT level was always higher in lymphoid compared to
nonlymphoid organs. During chronic viral infection, CSFT
levels were elevated for extended periods on antigen-specific
effector CD8+ T cells. Finally, CSFT levels on effector CD8+ T
cells, regardless of infection, identify cells undergoing recent
TCR stimulation, not cytolytic capacity or proliferative status.
Taken together these data suggest that CD8+ T cells
upregulate CSFT following receptor ligation and ROI
production to prevent overoxidation of surface proteins.
Materials and Methods
Mice, virus and infections
Six to 8-week old female C57BL/6 mice were purchased
from the National Cancer Institute (Fredericksburg, MD). Mice
were infected with 2x105 p.f.u. of LCMV-Armstrong i.p., or
2x106 p.f.u. of LCMV-Clone 13 i.v. and used at the indicated
timepoints. For secondary infection mice were rechallenged
greater than 60 days postinfection following LCMV-Armstrong.
All studies were approved by the Institutional Animal Care and
Use Committee (IACUC) of the Wake Forest University School
of Medicine (Animal welfare assurance number A3391-01).
Virus stocks were grown and quantitated, as described
previously [10].
Priming of transgenic cells
Priming of P14 transgenic cells has been described before
[11]. In these studies either 104 or 105 naïve P14 Thy1.1+ cells
were transferred into naïve C57BL/6 (Thy1.2+) mice,
challenged with LCMV-Armstrong, and used at the indicated
timepoints.
Cell isolation
The spleen was removed from mice after cervical dislocation.
Following mechanical disruption of splenocytes on a wire mesh
screen, red blood cells were removed by osmotic lysis in ACK
lysis buffer (Lonza). Splenocytes were then resuspended in
RPMI 1640 supplemented with 10% FCS (Hyclone), L-
glutamine (Hyclone), penicillin-streptomycin (Cellgro), and β-
mercaptoethanol (Gibco). Bone marrow cells were extracted
from both femurs using a 23 gauge syringe and lysed in ACK
buffer to remove red blood cells. Lymph node cells were
isolated following mechanical disruption on a wire mesh
screen. Peripheral blood mononuclear cells (PBMC) were
isolated following retroorbital bleeding by Histopaque (Sigma)
gradient centrifugation. For isolation of nonlymphoid tissues,
mice were euthanized, the abdomen was opened, the hepatic
vein was cut, and 5 ml of ice-cold PBS was injected directly
into the hepatic artery to perfuse the liver. The gall bladder was
removed, and the entire liver was excised. The liver tissue was
homogenized with a wire screen and incubated in 0.25 mg of
collagenase B/ml (Boehringer Mannheim) and 1 U of DNase
(Sigma /ml at 37°C for 45 min. Digested liver was centrifuged,
and the pellet was resuspended in 5 to 10 ml of 44% Percoll
(Sigma). This solution was underlaid with 56% Percoll and
spun at 2,000 rpm for 20 min at 20°C. The intrahepatic
lymphocyte populations were harvested from the interface, and
red blood cells were lysed with 0.83% ammonium chloride,
washed, and counted. Lung lymphocytes were isolated in a
similar manner.
CD8+ T cell purification
CD8+ T cells were negatively selected by magnetic bead
enrichment from the spleens of naïve 6-8 week old mice using
the Miltenyi MicroBead system according to the manufacturer’s
protocol. Purity was >95% as determined by flow cytometry.
CFSE labeling
CFSE was purchased from Invitrogen Life Technologies and
dissolved in DMSO as a 5 mM stock. After purification cells
were washed three times in PBS and suspended at a
concentration of 2 x107 cells/ml in PBS. The CFSE stock was
diluted to 10 μM in PBS and mixed with cells 1:1 (v/v), resulting
in a final concentration of 5 μm CFSE. After 3 minutes,
samples were vortexed and then continued incubating for an
additional 2 minutes. After this time 1/10 of volume FCS was
added for 1 minute followed by vortexing. The cells were then
washed three times with complete medium and used in
experiments.
Surface Free Thiols on Virus-Specific CD8+ T Cells
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CD8+ T cell stimulation
For anti-CD3/CD28 stimulations, 48 well flat bottom plates
were coated with 10 μg/ml of anti-CD3 and anti-CD28
antibodies or 20μg/ml control IgG in PBS overnight at 4°C. All
antibodies were purchased from BD Pharmingen. After removal
of PBS, purified T cells were added at 3x105 cells per ml.
Flow cytometry and FACS analysis
Samples were acquired on a CANTO II instrument (BD
Biosciences) and data were analyzed using FloJo software
(TreeStar).
Detection of cell surface free thiols
Maleimide-Alexa Fluor 488, maleimide-Alexa Fluor 647, and
maleimide-Pacific Blue were purchased from Invitrogen and
dissolved in DMSO as 2.5mM stock. To assess CSFT, cells
were incubated in 5μM maleimide-conjugate in 1% FCS in
RPMI for 15 minutes on ice and then surface stained and fixed.
In the pretreatment experiments cells were washed 3 times
with PBS, followed by a 15 minute incubation with 5mM N-
ethylmaleimide or dithiothreitol (DTT). Cells were then washed
3 times and incubated with fluorescently conjugated maleimide.
Surface and intracellular staining
In this study the following Abs were used: rat anti-mouse
CD8α-PE, rat anti-mouse CD8 α -PerCP, rat anti-mouse CD8 α
-APC, rat anti-mouse CD127-FITC, rat anti-mouse CD44-FITC,
rat anti-mouse CD4-PE, rat anti-mouse CD90.1-FITC, rat anti-
mouse KLRG1-PE, , rat anti-mouse CD69-PE, rat anti-mouse
Granzyme B-PE, mouse anti-human Ki-67-PE and hamster
anti-mouse PD-1. KLRG1 antibody was purchased from
Abcam. CD127 and PD-1 antibodies were purchased from
eBioscience. All other antibodies were purchased from BD
Pharmingen. DbGP33-41, DbNP396-404, DbGP276-286 MHC
class I tetramers were generated as previously described [12].
Surface staining was performed by incubation of Abs at a 1:100
dilution in FACS buffer for 30 min at 4°C. KLRG1 staining was
performed at a 1:25 dilution. CD90.1 staining was performed at
a 1:750 dilution. To measure intracellular Granzyme B levels,
cells were treated with BD Biosciences Cytofix/Cytoperm kit
according to the manufacturer’s instructions. To measure Ki-67
staining cells were stained with the BD FACS Lysing and
Permeability Solutions kit according to the manufacturer’s
instructions.
Statistical analysis
Data were analyzed using a two-tailed student’s t test, and
p< 0.05 was considered significant.
Results
Cell Surface Free Thiols Are Increased On Effector/
Memory Compared To Naïve Phenotype CD8+ T Cells
To understand how cell surface free thiols (CSFT) change
with CD8+ T cell activation and differentiation we performed
flow cytometry using fluorescently labeled conjugates of
maleimide. This chemical probe specifically reacts with the thiol
group found in cysteine to form a stable carbon sulfur bond and
allows changes in surface protein oxidation to be monitored. To
verify that staining was specific, splenocytes were pretreated
with media, excess unlabeled maleimide or DTT and then
incubated with maleimide conjugated with Alexa Fluor 488.
Figure 1A & B show that pretreatment with maleimide
decreases 88% of signal. Conversely, pretreatment with DTT
resulted in a 15-fold increase cell surface free thiol staining.
Taken together, these data demonstrate the probe is
specifically measuring free thiols on the surface of cells. To
understand how CSFT change during T cell development,
thymocytes were isolated and stained with anti-CD8, anti-CD4
and fluorescently labeled maleimide (Figure 1C). CSFT were
significantly higher on CD8 SP compared to CD4 SP or
CD8CD4 DP T cells (Figure 1D). When splenocytes were
interrogated CSFT levels were increased 1.5-fold in
CD8+CD44hi activated/memory cells compared to naïve
CD8+CD44low T cells (Figure 1E) and similar trends were
observed in the lymph nodes and bone marrow (Figure 1F).
Thus CSFT increase during T cell maturation and are higher on
activated/memory compared to naïve phenotype CD8+ T cells.
Cell Surface Free Thiols Increase On Activated CD8+ T
Cells Prior To The First Division
To understand how CSFT change on CD8+ T cells during
activation, purified T cells were labeled with CFSE and CSFT
levels were assessed as cells began to divide. Figure 2A
shows that after 24 hours, isotype stimulated CD8+ T cells had
low levels of CSFT whereas those on anti-CD3/CD28
stimulated cells had increased. Importantly, this increase was
independent of CFSE dilution demonstrating that it did not
require division. From day 1 to 3 cells underwent multiple
divisions and the CSFT levels increased further. When the
results were quantitated from multiple experiments ~3-fold
increase in CSFT could be observed at 12 hours compared to
isotype stimulated cells (Figure 2B). By 24 hours CSFT levels
increased 10-fold compared to isotype treated cells and this
continued to rise at 48 and 72 hours. In contrast incubation with
IFNα or IL-12 did not raise CSFT above the levels detected on
isotype treated cells (data not shown). Thus CSFT levels
initially increase prior to division and continue to rise as cells
proliferate.
Cell Surface Free Thiols Are Increased On Effector
Compared To Memory CD8+ T Cells During Acute Viral
Infection
To understand how CSFT levels change in vivo as CD8+ T
cells become activated and differentiate we infected mice with
LCMV-Armstrong. This virus induces an acute infection that will
be cleared in 8 to 9 days and will generate lifelong CD8+ T cell-
mediated immunity. Using MHC Class I tetramers to three Db-
restricted LCMV epitopes (GP33-41, NP396-404, and
GP276-286) we determined that CSFT were increased ~4-fold
on antigen-specific CD8+ T cells at the peak of the effector
response compared to naïve phenotype (CD8+CD44low) T cells
from uninfected mice (Figure 3A). When an extended
timecourse was examined the greatest levels of CSFT (7-9 fold
increase) were observed at day 5 postinfection when high
Surface Free Thiols on Virus-Specific CD8+ T Cells
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levels of virus are present (Figure 3B). From day 5 to 8
postinfection antigen-specific CD8+ T cells increase 10-fold, but
the levels of CSFT decline on a per cell basis. After viral
clearance, the levels of CSFT decline further and by the time
the memory phase was reached levels were elevated slightly
compared to naïve cells. When LCMV-Armstrong infected mice
were rechallenged with LCMV-Clone 13 a vigorous secondary
expansion was induced that peaked 5 days postinfection [11].
The CSFT levels on secondary effector CD8+ T cells increase
~4-fold compared to those found on naïve T cells reaching a
Figure 1.  Cell Surface Free Thiols Are Increased On Memory Compared To Naïve Phenotype CD8+ T Cells.  (A) Splenocytes
from naive mice were pretreated with either media, 5mM N-ethylmaleimide (NEM) or 5mM dithiothretiol (DTT) and then incubated
with media (mock) or 5μM maleimide-Alexa Fluor 488 and the fluorescence is plotted as a histogram. (B) The maleimide-Alexa
Fluor 488 geometric mean for mock splenocytes was used as the baseline and the fold increase of the other populations was
determined the average and standard deviation are plotted. (C) Thymocytes were isolated from naïve mice and then stained with
anti-CD8α and anti-CD4 and maleimide-Alexa Fluor 488. The dot plot is gated on viable cells and the maleimide-Alexa Fluor 488
level for each population is plotted as a histogram (D) The maleimide-Alexa Fluor 488 geometric mean for CD4 SP T cells was used
as the baseline and the fold increase of the other populations was determined the average and standard deviation are plotted. (E)
Splenocytes were isolated from naïve mice and then stained with anti-CD8α and anti-CD44 and maleimide-Alexa Fluor 488. The dot
plot is gated on viable cells and the maleimide-Alexa Fluor 488 level for each population is plotted as a histogram (F) The geometric
mean for each population in the spleen, lymph node and bone marrow was determined and the average and standard deviation are
plotted. Six mice were analyzed in two independent experiments. *, significant difference, P<0.05.
doi: 10.1371/journal.pone.0081134.g001
Surface Free Thiols on Virus-Specific CD8+ T Cells
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level comparable to those on primary effector cells at the peak
of the response on day 8 (Figure 3B). Thus CSFT are elevated
on both primary and secondary effector compared to naïve and
memory CD8+ T cells.
Cell Surface Free Thiols Are Highest On Antigen-
Specific CD8+ T Cells In Lymphoid Organs
To understand how CSFT change on CD8+ T cells in various
tissues during infection we utilized P14 TCR transgenic mice.
These mice express a TCR that recognizes the Db-restricted
epitope GP33-41 of LCMV. These cells also allow direct
measurement of CSFT changes on the same cell as it
differentiates from naïve to effector to memory. Figure 4A
shows that following adoptive transfer of a small number of
Thy1.1+ P14 cells into congenic C57BL/6 hosts a massive
expansion was induced and the DbGP33-41 specific response
was almost completely transgenic. When CSFT were
measured, naïve P14 cells had a geometric mean of 29.4 that
increased to 103 by day 8 postinfection (effector) and declined
to 81.9 when the memory phase was reached. Importantly,
there was minimal difference in the forward scatter of the
various populations demonstrating the changes observed in
CSFT level were not solely due to cell size. During LCMV
infection antigen-specific CD8+ T cells expanded in multiple
tissues. On day 8 (Figure 4B) and 79 (Figure 4C) postinfection
cells were harvested from various organs and the CSFT levels
were measured. During both the effector and memory phases
CSFT levels were the highest in lymphoid organs such as the
Figure 2.  Cell Surface Free Thiols Increase On Activated CD8+ T Cells Prior To Division.  Splenocytes were isolated from
naïve mice and CD8+ T cells were purified and labeled with CFSE. Cells were then stimulated with either 10μg/mL isotype or anti-
CD3 and anti-CD28. At the indicated timepoint, cells were harvested and incubated with maleimide-Alexa Fluor 647. Proliferation
(A) was assessed by loss of CFSE fluorescence after activation. (B) The fold increase in cell surface free thiols relative to those
found on isotype stimulated cells was determined and the average and standard deviation are plotted. Six mice were analyzed in
two independent experiments. *, significant difference, P<0.05.
doi: 10.1371/journal.pone.0081134.g002
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spleen, lymph nodes and bone marrow. Indeed the CSFT
levels in the lymph nodes and spleen either decreased (lymph
nodes) or remained constant (spleen), but in the bone marrow
staining increased between effector and memory CD8+ T cells.
When nonlymphoid tissues were examined, CSFT levels were
always less than lymphoid tissues and were lower at both
timepoints in the lung. Thus CSFT are highest on antigen-
specific CD8+ T cells in lymphoid tissues.
To better understand the relationship between CSFT and T
cell differentiation we adoptively transferred P14 cells and
examined the early differentiation of effector CD8+ T cells. Prior
studies by Kalia and colleagues have demonstrated that
prolonged IL-2 receptor alpha chain expression (CD25) is
correlated with terminal differentiation into CD127lowKLRG1high
short lived effector cells (SLEC) [13]. In Figure 5A effector cells
from days 3.5 to 8 postinfection were examined for the
expression of CD25 and CSFT. On day 3.5 postinfection ~94%
of effector cells expressed a broad range of CD25.
Interestingly, cells with an intermediate level of CD25 had the
highest level of CSFT. As the infection progressed CD25 levels
declined on day 5 and by day 8 postinfection almost all of the
cells had CD25 expression similar to naïve T cells. At the later
timepoints P14 cells that possessed increased expression of
CD25 had the highest level of CSFT. Thus early during effector
differentiation cells with intermediate levels of CD25 expression
possessed the highest levels of CSFT, but as differentiation
proceeded cells that maintained their CD25 expression also
had high CSFT.
Effector CD8 T cell development culminates with
differentiation into four subsets: CD127lowKLRG1low early
effector cells (EEC), CD127lowKLRG1high short lived effector
cells (SLEC), CD127highKLRG1high double positive effector cells
(DPEC) and CD127highKLRG1low memory precursor cells
(MPEC) [14]. Most of the SLEC will undergo apoptosis while
the MPEC, and DPEC to a lesser extent, will give rise to long-
lived memory cells. By day 8 postinfection most of the P14
cells had differentiated into SLEC (62.9%, Figure 5B), while the
remaining cells were split amongst the other populations. When
CSFT were measured, DPEC had the highest level while the
other three populations expressed similar amounts. In the
Figure 3.  Cell Surface Free Thiols Are Higher On Effector Compared To Memory CD8+T Cells During Acute Infection.  (A)
Mice were infected with LCMV-Armstrong and on day 8 postinfection splenocytes were harvested and stained with anti-CD8α, anti-
CD44, the indicated MHC Class I tetramer and maleimide-Alexa Fluor 488. The maleimide-Alexa Fluor 488 levels of the gated
populations are plotted in the histogram format with the shaded area indicating the staining of CD8+CD44lo T cells from naïve mice.
(B) Mice were examined at multiple times following LCMV- Armstrong (1°) infection or Clone 13 rechallenge (2°) and the fold
increase in cell surface free thiols relative to naïve phenotype cells from uninfected mice was determined and the average and
standard deviation are plotted. Six mice were analyzed in two independent experiments. *, significant difference, P<0.05.
doi: 10.1371/journal.pone.0081134.g003
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memory phase (Figure 5C) a mixture of KLRG1high and low
cells remained 79 days postinfection. Again CSFT were the
Figure 4.  Cell Surface Free Thiols Are Highest On Antigen-Specific Cells In Lymphoid Tissues.  (A) A total of 104 naïve P14
cells were transferred into naïve C57BL/6 hosts. Four hours later mice were infected with LCMV-Armstrong and harvested either 8
(Effector) or 79 (Memory) days later. Splenocytes were incubated with maleimide-Alexa Fluor 488,anti-CD8α, anti-CD90.1 and
DbGP33-41 MHC Class I tetramer. The maleimide-Alexa Fluor 488 and forward scatter levels of the gated populations are plotted in
the histogram format with the geometric mean indicated by the value in the upper right hand corner of the plot. The fold increase in
cell surface free thiols compared to naïve P14 cells during either the effector (B) or memory (C) phases was determined for P14
cells in the indicated tissues. The average and standard deviation are plotted. Six mice were analyzed in two independent
experiments. *, significant difference, P<0.05 between naïve P14 and cells from the indicated tissues.
doi: 10.1371/journal.pone.0081134.g004
Surface Free Thiols on Virus-Specific CD8+ T Cells
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highest on CD127highKLRG1high T cells. Thus CSFT are
increased to the greatest extent on CD127highKLRG1high CD8+ T
cells during both the effector and memory phases.
Prolonged Elevation Of Cell Surface Free Thiols During
Chronic Viral Infection
Because CSFT were elevated during the effector phase of
an acute antiviral immune response we wanted to determine
levels under conditions where antigen persisted. To address
this question we infected mice with LCMV-Clone 13 that
induces a chronic viral infection where antigen persists in
tissues for extended periods [15]. At the peak of effector
response on day 8 postinfection, splenocytes were harvested
and CSFT levels were measured on antigen-specific CD8+ T
cells using LCMV-specific tetramers. Figure 6A shows that
CSFT were increased 9 to 12-fold compared to naïve
phenotype cells from uninfected mice. When early timepoints
were examined (Figure 6B), similar to acute infection CSFT
were increased ~10-fold on day 5 postinfection. From day 5 to
8 postinfection CSFT levels remained constant and this was
maintained though 15 days. By day 35 postinfection, when viral
load is lowered in the spleen, CSFT levels had decreased
although these were still higher than those found during acute
infection. Thus CSFT remain elevated on antigen-specific CD8+
T cells for extended periods during chronic infection.
Cell Surface Free Thiol Expression Identifies Effector
CD8+ T Cells Undergoing Recent TCR Stimulation
Prior studies have suggested cells with increased CSFT
have a greater functional capacity [16], yet our results
document that CSFT are higher on antigen-specific CD8+
effector T cells from chronic LCMV infection compared to
memory cells generated following acute LCMV infection. This
distinction is critical because during chronic infection virus-
specific CD8+ T cells undergo exhaustion decreasing cytokine
production and cytolysis, whereas polyfunctional memory cells
are rapidly able to produce cytokines and kill infected cells [15].
Because agents such as monensin, which block transit through
the ER, decrease CSFT, assessing function by intracellular
cytokine staining is problematic. To measure functional
capacity in the absence of peptide restimulation we performed
intracellular staining for Granzyme B. Splenocytes were
Figure 5.  Double Positive Effector Cells Have the Largest Increase In Cell Surface Free Thiols.  To assess cell surface free
thiol expression during the early differentiation of CD8+ T cells a total of 105 naïve P14 cells were transferred into naïve C57BL/6
hosts. Four hours later mice were infected with LCMV-Armstrong and harvested at the indicated timepoint. (A) Splenocytes were
incubated with maleimide-Pacific Blue, anti-CD8α, anti-CD90.1 and anti-CD25. Dot plots are gated on CD8+CD90.1+ T cells and the
value in the upper right hand corner of the plot indicates the percent of cells in that quadrant. (B) To determine the expression of cell
surface free thiols during later timepoints in the differentiation process a total of 104 naïve P14 cells were transferred into naïve
C57BL/6 hosts. Four hours later mice were infected with LCMV-Armstrong and harvested at the indicated timepoint. Splenocytes
were incubated with maleimide-Alexa Fluor 488, anti-CD8α, anti-CD90.1, anti-CD127 and anti-KLRG1. The expression of cell
surface free thiols was examined in the effector (B) or memory (C) phases using P14 cells. Dot plots are gates on CD8+CD90.1+ T
cells and the value in the upper right hand corner of the plot indicates the percent of cells in that quadrant. The maleimide-Pacific
Blue level of the gated population is plotted in the histogram format.
doi: 10.1371/journal.pone.0081134.g005
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harvested from day 8 LCMV-Armstrong (acute infection) or
Clone 13 (chronic infection) and surface stained with anti-
CD8α, anti-CD44, DbGP33-41 and maleimide-Pacific Blue.
Figure 7A shows that during both infections a range of
Granzyme B staining was observed in antigen-specific CD8+ T
cells. CSFT were determined for LCMV-specific CD8+ T cells
that had negative, intermediate or high levels of Granzyme B
staining. Similar to our prior results, CSFT levels were higher
across all three epitopes in chronic compared to acute infection
but there was no correlation with granzyme B expression
(Figure 7B). In addition to decreased function antigen-specific
CD8+ T cells from acute versus chronic viral infection undergo
differential proliferation and TCR stimulation. To identify
proliferating cells MHC Class I tetramer+ cells were costained
with maleimide-Pacific Blue and anti-Ki-67. In both acute and
chronically infected mice most of the DbGP33-41 specific CD8+
T cells were undergoing division although a greater percentage
in chronic infection (Figure 7C) were dividing. When multiple
epitopes were examined (Figure 7D), CSFT were again
increased on effector cells from chronic compared to acute
infection, but no differences were observed between Ki-67
positive and negative cells. Since antigen persists for extended
periods in chronic compared to acute infection, we determined
whether CSFT level identified effector CD8+ T cells undergoing
recent TCR stimulation. Upon antigen stimulation CD8+ T cells
upregulate surface levels of CD69 and the inhibitory receptor
programmed death-1 (PD-1) [17]. By day 8 of acute infection
only a small proportion (~2.9%) of CD8+DbGP33-41+ T cells are
positive for both markers while 46.5% express increased PD-1
(Figure 7E). This contrasts with chronic infection where by day
8 postinfection 13.3% of DbGP33-41 specific CD8+ T cells
express high levels of both markers and 79.8% express
elevated PD-1. When CSFT were determined CD69highPD-1high
cells, regardless of the infection they were isolated from or
antigen-specificity, had the highest staining (Figure 7F). The
next highest levels were observed on CD69-PD-1high cells while
the CSFT on CD69-PD-1- cells were the lowest of any of the
populations. Taken together these results demonstrate that the
level of CSFT on effector CD8+ T cells indicates recent TCR
stimulation not functional capacity or proliferative status.
Discussion
In this study we examined the expression of CSFT during
CD8+ T cell development, activation, proliferation and
differentiation during viral infection. Here we report seven novel
Figure 6.  Cell Surface Free Thiols Remain Elevated On Antigen-Specific CD8+ T Cells For Extended Periods During
Chronic Viral Infection.  (A) Mice were infected with LCMV-Clone 13 and on day 8 postinfection, splenocytes were harvested and
stained with anti-CD8α, anti-CD44, the indicated MHC Class I tetramer and maleimide-Alexa 488. The maleimide-Alexa Fluor 488
level of the gated populations is plotted in the histogram format with the shaded area indicating the staining of CD8+CD44lo T cells
from naïve mice. (B) Mice were examined at multiple times following LCMV-Clone 13 infection and the fold increase in cell surface
free thiols relative to naïve phenotype cells from uninfected mice was determined and the average and standard deviation are
plotted. Six mice were analyzed in two independent experiments. *, significant difference, P<0.05.
doi: 10.1371/journal.pone.0081134.g006
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Figure 7.  Cell Surface Free Thiols Are Elevated On Antigen-Specific Cells Undergoing Recent TCR Stimulation.  Naïve mice
were infected with either LCMV-Armstrong (Acute) or LCMV-Clone 13 (Chronic) and harvested 8 days postinfection. To determine if
cell surface free thiol levels correlated with expression of granzyme B (A), splenocytes were stained with anti-CD8α, DbGP33-41,
isotype control or anti-Granzyme B and maleimide-Alexa Fluor 488. The histogram is gated on CD8+DbGP33-41+ T cells and the
shaded area indicates isotype staining. For each population the Granzyme B expression was divided into negative (neg),
intermediate (int) , and high (high) levels of staining. (B) The cell surface free thiol levels compared to those on
CD8+CD44loGranzyme B- T cells from uninfected mice were determined for each antigen-specific population and the average and
standard deviation are plotted. To determine whether cell surface free thiols were elevated on antigen specific CD8+ T cells that
were actively proliferating (C) splenocytes were stained with anti-CD8α, DbGP33-41, isotype control or anti-Ki-67, and maleimide-
Alexa Fluor 488 . Dot plots are gated on total CD8+ T cells and the values in each corner indicate the percent of cells that are in that
quadrant. (D) The cell surface free thiol levels compared to those on CD8+CD44loKi-67- T cells from uninfected mice were
determined for each antigen-specific population and the average and standard deviation are plotted. (E) To determine recent TCR
stimulation splenocytes were stained with anti-CD8α, anti-CD69, anti-PD-1, DbGP33-41 and maleimide-Pacific Blue. The dot plots
are gated on either CD8+CD44lo (naïve) or CD8+DbGP33-41+ (infected) T cells. The value in each corner indicates the percent of
cells in that quadrant. (F) The cell surface free thiol levels compared to those on CD8+PD-1-CD69- T cells from uninfected mice were
determined for each antigen-specific population and the average and standard deviation are plotted. Six mice were analyzed in two
independent experiments. *, significant difference between acute and chronic infection, P<0.05.
doi: 10.1371/journal.pone.0081134.g007
Surface Free Thiols on Virus-Specific CD8+ T Cells
PLOS ONE | www.plosone.org 10 November 2013 | Volume 8 | Issue 11 | e81134
observations. First, CSFT are increased on developing CD8 SP
compared to CD4 SP or CD8CD4 DP T cells in the thymus.
Second, after emigration to the periphery CSFT are higher on
activated/memory compared to naïve phenotype CD8+ T cells.
Third, during activation CSFT increase on CD8+ T cells prior to
division, and become further elevated with proliferation. Fourth,
during acute viral infection CSFT become elevated on antigen-
specific effector CD8+ T cells and decline as they differentiate
into memory cells. Fifth, CSFT are highest on antigen-specific
CD8+ T cells from lymphoid tissues during infection. Sixth,
during chronic viral infection, CSFT are elevated on antigen-
specific CD8+ T cells for extended periods. Seventh, during
infection the level of CSFT identifies effector cells undergoing
recent TCR stimulation not active cycling or expression of
cytolytic molecules.
What are the implications of our observed changes in CSFT
for early activation? It is well established that naïve CD8+ T
cells require three signals for optimal activation and
differentiation: (i) TCR recognition of cognate peptide MHC
complexes, (ii) interaction with costimulatory molecules and (iii)
programming by inflammatory cytokines [18]. Recently
evidence has emerged that production of ROI is another critical
event for T cell activation. Although levels are low in naïve
CD8+ T cells, within 15 minutes of cognate peptide stimulation
ROI increase 100% [3]. This increase is essential for activation
as antioxidant treatment, which lowers ROI, decreases T cell
activation [4]. Since H2O2 can readily diffuse across
membranes mechanisms must exist to prevent inappropriate
surface receptor oxidation and allow sustained TCR signaling.
Here we show that within hours of naïve CD8+ T cell activation
in vitro the total level of CSFT increases prior to division. As
cells divide CSFT levels increase further. Exposure of naïve
CD8+ T cells to costimulation or inflammatory cytokines in the
absence of TCR stimulation had minimal effect (data not
shown). Taken together these data suggest ROI and CSFT rise
in a coordinated fashion in response to TCR stimulation to
prevent overoxidation of the cell surface. The source of
increased CSFT is unclear. Formally the increase observed in
our and other studies could be due to new protein synthesis
and export to the surface or reduction of disulfide bonds in
surface proteins. Evidence for localization of new proteins to
the surface is provided by studies using monensin which
decreased CSFT on human PBMCs [9]. Alternatively treating
cells with N-Acetyl-cysteine or an analog that cannot be used in
intracellular glutathione synthesis, N-acetyl-D-cysteine raises
CSFT, supporting the idea that changes in the extracellular
redox state can modulate CSFT [19]. Identifying cell surface
proteins with free thiols has proven elusive. To date only a
small number of candidates that are exclusively surface
proteins have been identified. Using a proteomics based
approach Laragione and colleagues demonstrated that CSFT
in VLA-4 increased with NAC treatment and that this modulated
the interaction with fibronectin in an adhesion assay [19]. In
addition to VLA-4 other immunologically relevant protein-
protein interactions may be sensitive to CSFT status. Prior
studies by Kanner and colleagues have shown that the
interaction between CD4 and lck is blocked by NEM suggesting
free thiols are critical for this interaction [20]. In addition to
TCR-MHC-peptide interactions, cytokine signaling is critical for
T cell activation. Prior studies by Smith and colleagues
demonstrated agents that bind to CSFT decrease
responsiveness to IL-2 [8]. Although there is no evidence to
date that the interaction between costimulatory molecules and
their receptors on CD8+ T cells is regulated by oxidation, it is
tantalizing to speculate that this may be another extracellular
redox mechanism to fine tune T cell responses similar to the
modulation of cystine and cysteine levels by dendritic cells [21].
Taken together our results suggest that CSFT are
dynamically regulated in vivo during CD8+ T cell activation,
proliferation and differentiation. During development we
observed that CD8+ SP T cells had increased CSFT compared
to those on CD4 SP or CD4+CD8+ DP T cells. This confirms
and extends prior studies by Lawrence [9] and Sahaf et. al that
documented CSFT levels were higher on CD8+ compared to
CD4+ T cells isolated from patient’s PBMCs [22]. In vivo we
observed that early during infection (3.5-5 days), when antigen
and inflammatory cytokines would both be increased, CSFT
were elevated 10-fold or greater on antigen-specific CD8+ T
cells. In our prior studies we documented that superoxide
levels were increased in P14 cells 5 days postinfection
compared to naïve cells [23]. This again supports a role for
CSFT in preventing overoxidation of the cell surface. In vivo, as
the infection is brought under control from day 5 to 8,
superoxide and CSFT decline on antigen-specific CD8+ T cells.
Importantly the levels of CSFT were not equivalent amongst all
effector cells. We observed that EEC, SLEC and MPEC all had
similar levels of CSFT, while the highest levels were found on
DPEC. This subset of effector cells expresses high levels of
CD127 and KLRG1 and a portion of these cells will survive 181
days into the memory phase [14]. Although there are probably
multiple proteins with CSFT, murine KLRG1 has 10 cysteines
in its extracellular domain and these are used to form multiple
disulfide bonds both within the molecule and to facilitate
dimerization for interaction with E-cadherin [24,25]. This raises
the question whether the disulfide bond formation is altered in
DPEC compared to SLEC and how this would affect KLRG1’s
ability to negatively regulate TCR signaling. In memory CD8+ T
cells superoxide levels are lower than those found in naïve
CD8+ T cells, but CSFT are modestly elevated. Interestingly,
memory cells from later timepoints (days 79 or 97) have
increased CSFT compared to those from day 35 postinfection.
This increase in CSFT may represent another aspect in
memory differentiation similar to the conversion of CD62Llow
effector to CD62Lhigh central memory cells that occurs following
infection [26]. In support of this idea human CD8+ T cells
treated with IL-15 for a week during in vitro culture upregulate
CSFT [27]. Our results are also the first to measure CSFT
levels on antigen-specific effector CD8+ T cells during acute
and chronic viral infection. We have clearly shown that CSFT
remain elevated for prolonged periods on antigen-specific CD8+
T cells during chronic infection and are not a marker of cytolytic
capacity or proliferative status but rather indicate recent TCR
stimulation. In support of this idea, Sahaf and colleagues
demonstrated that CSFT were higher on CD4+ T cells from HIV
patients compared to healthy controls [22]. Although the
antigen specificity of these populations was not determined, in
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HIV patients there should be more activated CD4+ T cells with
increased CSFT. But, our studies contrast with those by
Gelderman and colleagues [16] who found that T cell surface
redox levels determine T cell reactivity and arthritis
susceptibility in an autoimmune model. In their study increased
CSFT were associated with increased IL-2 production, division
and ability to cause autoimmune disease following adoptive
transfer. Since they examined self-reactive CD4+ T cells it is
consistent with our studies that cells undergoing self-
stimulation in vivo would be CD69high and PD-1high and possess
increased CSFT. But our data clearly demonstrate that CSFT
do not correlate with the cytolytic capacity or proliferative status
of effector CD8+ T cells. Taken together they argue the role of
CSFT in T cell function is complex and may be differentially
regulated between CD4+ and CD8+ T cells during viral infection
and autoimmunity.
In conclusion we have shown that CSFT increase during the
activation, proliferation and differentiation of CD8+ T cells.
CSFT levels are highest on antigen-specific CD8+ T cells in
lymphoid organs and remain elevated during chronic infection.
Importantly, increased CSFT on antigen-specific effector CD8+
T cells identifies cells that have undergone TCR stimulation not
the expression of cytolytic molecules or proliferative status. The
demonstration that increased CSFT mark recently stimulated
effector T cells provides another marker to understand T cell
differentiation during infection and to develop therapies to
remove these cells during autoimmunity, graft versus host
disease and transplantation.
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